Like the findings with the GPR‐81 antagonist, GPR‐81 silencing clearly reduced α‐SMA levels in control fibroblasts while the levels of α‐SMA remained unaltered in IPF fibroblasts under the same conditions (Figure 8c, upper and lower). The gene discussed is HCAR1; the disease is idiopathic pulmonary fibrosis.